ACORN CAPITAL ADVISORS, LLC
22 holdingsFiling period: 2026-03-31Current AUM: $403.3Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TERN | TERNS PHARMACEUTICALS INC | 1.75M | $92.1M | $92.1M | 22.83% | -- | 2026-03-31 |
| 2 | CGON | CG ONCOLOGY INC | 1.13M | $76.6M | $80.6M | 19.97% | -1,000 | 2026-03-31 |
| 3 | — | UROGEN PHARMA LTD | 1.67M | $30.1M | $30.1M | 7.46% | +225.0K | 2026-03-31 |
| 4 | PBYI | PUMA BIOTECHNOLOGY INC | 4.13M | $26.4M | $32.8M | 8.12% | -- | 2026-03-31 |
| 5 | TRVI | TREVI THERAPEUTICS INC | 2.14M | $25.6M | $39.1M | 9.71% | -- | 2026-03-31 |
| 6 | CADL | CANDEL THERAPEUTICS INC | 3.50M | $17.2M | $35.2M | 8.72% | +917.4K | 2026-03-31 |
| 7 | BCAX | BICARA THERAPEUTICS | 643.4K | $12.8M | $17.4M | 4.32% | -- | 2026-03-31 |
| 8 | OKUR | ONKURE THERAPEUTICS INC | 2.84M | $11.8M | $10.8M | 2.69% | -- | 2026-03-31 |
| 9 | JBIO | JADE BIOSCEINCES INC | 786.8K | $11.1M | $15.5M | 3.85% | -- | 2026-03-31 |
| 10 | TARA | PROTARA THERAPEUTICS INC | 1.75M | $9.1M | $6.9M | 1.70% | -- | 2026-03-31 |
| 11 | VSTM | VERASTEM INC | 1.47M | $7.8M | $8.5M | 2.11% | -- | 2026-03-31 |
| 12 | HELP | HELUS PHARMA INC. | 1.54M | $7.4M | $12.0M | 2.99% | -32,757 | 2026-03-31 |
| 13 | LONA | LEONABIO, INC. | 634.5K | $6.5M | $4.5M | 1.11% | +132.8K | 2026-03-31 |
| 14 | AURA | AURA BIOSCIENCES INC | 595.7K | $4.0M | $4.2M | 1.04% | -- | 2026-03-31 |
| 15 | WHWK | WHITEHAWK THERAPEUTICS INC | 1.14M | $3.9M | $4.4M | 1.09% | -- | 2026-03-31 |
| 16 | CRDF | CARDIF ONCOLOGY INC | 1.76M | $2.9M | $1.5M | 0.37% | -200,000 | 2026-03-31 |
| 17 | QTTB | Q32 BIO INC. | 315.1K | $2.0M | $4.9M | 1.22% | -178,373 | 2026-03-31 |
| 18 | KPTI | KARYOPHARM THERAPEUTICS INC | 287.8K | $1.6M | $553K | 0.14% | -- | 2026-03-31 |
| 19 | JSPR | JASPER THERAPEUTICS | 1.41M | $1.2M | $893K | 0.22% | -375,000 | 2026-03-31 |
| 20 | ASNS | X4 PHARMACEUTICALS INC | 234.0K | $966K | $966K | 0.24% | -39,310 | 2026-03-31 |
| 21 | BCAB | BIOATLA INC | 5.41M | $865K | $354K | 0.09% | +571.2K | 2026-03-31 |
| 22 | VYNE | VYNE THERAPEUTICS INC | 1.4K | -- | -- | -- | -- | 2026-03-31 |
← Scroll →